⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 25, 2022Indian Journal of OphthalmologyOpen Access

Comparison of once daily dose of 0.3% nepafenac alone and three times dose of 0.1% nepafenac alone in pain and inflammation control after phacoemulsification

View Full Paper

Ask AI

Bookmark

Share

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

A 2022 study studied this question.

synapsesocial.com/papers/6a96de2231394ac286fbda9b https://doi.org/10.4103/ijo.ijo_2401_21

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Perioperative antibiotics and anti-inflammatory agents in cataract surgery2007 · 50 citations
2Comparison between 0.1% Nepafenac and 1% Prednisolone Eye Drop in Postoperative Management Following Micro-incisional Cataract Surgery2021 · 10 citations
3Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery2006 · 78 citations
4Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients2011 · 11 citations
5Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: Phase 3 study2013 · 43 citations